McKesson Corporation  

(Public, NYSE:MCK)   Watch this stock  
Find more results for MCK
+3.66 (1.96%)
Oct 9 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 186.10 - 190.40
52 week 160.10 - 243.61
Open 186.21
Vol / Avg. 2.78M/1.99M
Mkt cap 43.29B
P/E 22.99
Div/yield 0.28/0.59
EPS 8.26
Shares 232.00M
Beta 1.04
Inst. own 87%
Oct 29, 2015
Q2 2016 McKesson Corp Earnings Release - 9:30AM EDT - Add to calendar
Oct 29, 2015
Q2 2016 McKesson Corp Earnings Call - 8:30AM EDT - Add to calendar
Sep 18, 2015
UDG Healthcare PLC Proposed Sale of United Drug Supply Chain Businesses and MASTA to McKesson Corporation and Leadership Transition Call
Sep 16, 2015
McKesson Corp at Morgan Stanley Healthcare Conference
Sep 9, 2015
McKesson Corp at FBR Healthcare Conference
Jul 30, 2015
McKesson Corp Annual Shareholders Meeting (Estimated)
Jul 29, 2015
Q1 2016 McKesson Corp Earnings Call
Jul 29, 2015
Q1 2016 McKesson Corp Earnings Release
Jul 29, 2015
McKesson Corp Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2015
Net profit margin 1.26% 1.03%
Operating margin 1.96% 1.66%
EBITD margin - 2.43%
Return on average assets 4.38% 3.49%
Return on average equity 27.89% 21.49%
Employees 70,400 -
CDP Score - -


1 Post St
SAN FRANCISCO, CA 94104-5203
United States - Map
+1-415-9838300 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.

Officers and directors

John Harvey Hammergren Chairman of the Board, President, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
James A. Beer Chief Financial Officer, Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Kathleen D. McElligott Executive Vice President, Chief Technology Officer, Chief Information Officer
Age: 59
Bio & Compensation  - Reuters
Lori A. Schechter Executive Vice President, Chief Compliance Officer, General Counsel
Age: 53
Bio & Compensation  - Reuters
Jorge L. Figueredo Executive Vice President - Human Resources
Age: 54
Bio & Compensation  - Reuters
Patrick J. Blake Executive Vice President, Group President
Age: 51
Bio & Compensation  - Reuters
Paul Coleman Julian Executive Vice President, Group President
Age: 60
Bio & Compensation  - Reuters
Bansi Nagji Executive Vice President - Corporate Strategy and Business Development
Age: 50
Bio & Compensation  - Reuters
Edward A. Mueller Lead Director
Age: 68
Bio & Compensation  - Reuters
Andrew D. Bryant Independent Director
Age: 65
Bio & Compensation  - Reuters